{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:01:23Z","timestamp":1790949683304,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"International Waldenstrom Macroglobulinemia Foundation and Predolin Foundation"},{"DOI":"10.13039\/100001695","name":"International Waldenstrom's Macroglobulinemia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-024-01173-w","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T06:49:53Z","timestamp":1734504593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity"],"prefix":"10.1038","volume":"14","author":[{"given":"Vaishali","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-2300","authenticated-orcid":false,"given":"Zhi-Zhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2907-0809","authenticated-orcid":false,"given":"Jose C.","family":"Villasboas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Mudappathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4432-4707","authenticated-orcid":false,"given":"Junwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithviraj","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7350-5531","authenticated-orcid":false,"given":"Jonas","family":"Paludo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-8085","authenticated-orcid":false,"given":"Jordan E.","family":"Krull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7904-1651","authenticated-orcid":false,"given":"Anne J.","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0355-3757","authenticated-orcid":false,"given":"Patrizia","family":"Mondello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-6758","authenticated-orcid":false,"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"1173_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ajh.26082","volume":"96","author":"MA Gertz","year":"2021","unstructured":"Gertz MA. Waldenstr\u00f6m macroglobulinemia: 2021 update on diagnosis, risk stratification, and management. Am J Hematol. 2021;96:258\u201369.","journal-title":"Am J Hematol"},{"key":"1173_CR2","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1200\/JCO.19.02314","volume":"38","author":"SP Treon","year":"2020","unstructured":"Treon SP, Xu L, Guerrera ML, Jimenez C, Hunter ZR, Liu X, et al. Genomic landscape of Waldenstr\u00f6m macroglobulinemia and its impact on treatment strategies. J Clin Oncol. 2020;38:1198\u2013208.","journal-title":"J Clin Oncol"},{"key":"1173_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N. Engl J Med. 2012;367:826\u201333.","journal-title":"N. Engl J Med"},{"key":"1173_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679\u201390.","journal-title":"Nat Med"},{"key":"1173_CR5","doi-asserted-by":"crossref","unstructured":"Watanabe J, Natsumeda M, Okada M, Kobayashi D, Kanemaru Y, Tsukamoto Y, et al. High detection rate of MYD88 mutations in cerebrospinal fluid from patients with CNS lymphomas. JCO Precis Oncol. 2019;3:1\u201313.","DOI":"10.1200\/PO.18.00308"},{"key":"1173_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/pin.12336","volume":"65","author":"N Oishi","year":"2015","unstructured":"Oishi N, Kondo T, Nakazawa T, Mochizuki K, Tanioka F, Oyama T, et al. High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses. Pathol Int. 2015;65:528\u201335.","journal-title":"Pathol Int"},{"key":"1173_CR7","doi-asserted-by":"crossref","unstructured":"Mondello P, Paludo J, Novak JP, Wenzl K, Yang Z-Z, Jalali S, et al. Molecular clusters and tumor-immune drivers of IgM monoclonal gammopathies. Clin Cancer Res. 2022;29:957\u2013970.","DOI":"10.1158\/1078-0432.CCR-22-2215"},{"key":"1173_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/2643-3230.BCD-21-0043","volume":"2","author":"A Kaushal","year":"2021","unstructured":"Kaushal A, Nooka AK, Carr AR, Pendleton KE, Barwick BG, Manalo J, et al. Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation, and MyD88-mutant progenitors precede waldenstrom macroglobulinemia. Blood Cancer Discov. 2021;2:600\u201315.","journal-title":"Blood Cancer Discov"},{"key":"1173_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1129343","volume":"11","author":"V Bhardwaj","year":"2023","unstructured":"Bhardwaj V, Ansell SM. Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies. Front Cell Dev Biol. 2023;11:1129343.","journal-title":"Front Cell Dev Biol"},{"key":"1173_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021;21:485\u201398.","journal-title":"Nat Rev Immunol"},{"key":"1173_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/0008-5472.CAN-06-3037","volume":"67","author":"DI Gabrilovich","year":"2007","unstructured":"Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007;67:425.","journal-title":"Cancer Res"},{"key":"1173_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162\u201374.","journal-title":"Nat Rev Immunol"},{"key":"1173_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.616","volume":"10","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang J, Zhu F, Wang H, Yi L, Huang K, et al. Elevated circulating myeloid-derived suppressor cells associated with poor prognosis in B-cell non-Hodgkin\u2019s lymphoma patients. Immun Inflamm Dis. 2022;10:e616.","journal-title":"Immun Inflamm Dis"},{"key":"1173_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/ijlh.12203","volume":"36","author":"KA Khalifa","year":"2014","unstructured":"Khalifa KA, Badawy HM, Radwan WM, Shehata MA, Bassuoni MA. CD14(+) HLA-DR low\/(-) monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma. Int J Lab Hematol. 2014;36:650\u20135.","journal-title":"Int J Lab Hematol"},{"key":"1173_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1182\/blood-2015-08-662783","volume":"128","author":"I Azzaoui","year":"2016","unstructured":"Azzaoui I, Uhel F, Rossille D, Pangault C, Dulong J, Le Priol J, et al. T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells. Blood. 2016;128:1081\u201392.","journal-title":"Blood"},{"key":"1173_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/hon.2019","volume":"31","author":"T Tadmor","year":"2013","unstructured":"Tadmor T, Fell R, Polliack A, Attias D. Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells. Hematol Oncol. 2013;31:65\u201371.","journal-title":"Hematol Oncol"},{"key":"1173_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.seminhematol.2023.03.009","volume":"60","author":"SP Treon","year":"2023","unstructured":"Treon SP, Tedeschi A, San-Miguel J, Garcia-Sanz R, Anderson KC, Kimby E, et al. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom\u2019s macroglobulinemia on diagnostic and response criteria. Semin Hematol. 2023;60:97\u2013106.","journal-title":"Semin Hematol"},{"key":"1173_CR18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.exphem.2007.05.022","volume":"35","author":"D Ditzel Santos","year":"2007","unstructured":"Ditzel Santos D, Ho AW, Tournilhac O, Hatjiharissi E, Leleu X, Xu L, et al. Establishment of BCWM.1 cell line for Waldenstr\u00f6m\u2019s macroglobulinemia with productive in vivo engraftment in SCID-hu mice. Exp Hematol. 2007;35:1366\u201375.","journal-title":"Exp Hematol"},{"key":"1173_CR19","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1182\/blood-2010-12-326868","volume":"117","author":"LS Hodge","year":"2011","unstructured":"Hodge LS, Novak AJ, Grote DM, Braggio E, Ketterling RP, Manske MK, et al. Establishment and characterization of a novel Waldenstr\u00f6m macroglobulinemia cell line, MWCL-1. Blood. 2011;117:e190\u2013e7.","journal-title":"Blood"},{"key":"1173_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/(SICI)1097-0320(19961215)26:4<305::AID-CYTO11>3.0.CO;2-V","volume":"26","author":"M Mardiney 3rd","year":"1996","unstructured":"Mardiney M 3rd, Brown MR, Fleisher TA. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals. Cytometry. 1996;26:305\u201310.","journal-title":"Cytometry"},{"key":"1173_CR21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1158\/1078-0432.CCR-22-2215","volume":"29","author":"P Mondello","year":"2023","unstructured":"Mondello P, Paludo J, Novak JP, Wenzl K, Yang ZZ, Jalali S, et al. Molecular clusters and tumor-immune drivers of IgM monoclonal gammopathies. Clin Cancer Res. 2023;29:957\u201370.","journal-title":"Clin Cancer Res"},{"key":"1173_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2019","unstructured":"Becht E, McInnes L, Healy J, Dutertre C-A, Kwok IWH, Ng LG, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2019;37:38\u201344.","journal-title":"Nat Biotechnol"},{"key":"1173_CR23","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1172\/JCI84431","volume":"126","author":"SE Corcoran","year":"2016","unstructured":"Corcoran SE, O\u2019Neill LA. HIF1\u03b1 and metabolic reprogramming in inflammation. J Clin Investig. 2016;126:3699\u2013707.","journal-title":"J Clin Investig"},{"key":"1173_CR24","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","volume":"207","author":"CA Corzo","year":"2010","unstructured":"Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, et al. HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 2010;207:2439\u201353.","journal-title":"J Exp Med"},{"key":"1173_CR25","doi-asserted-by":"publisher","first-page":"e1490853","DOI":"10.1080\/2162402X.2018.1490853","volume":"7","author":"P Jayaraman","year":"2018","unstructured":"Jayaraman P, Parikh F, Newton JM, Hanoteau A, Rivas C, Krupar R, et al. TGF-\u03b21 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy. Oncoimmunology. 2018;7:e1490853.","journal-title":"Oncoimmunology"},{"key":"1173_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/01.pas.0000213412.25935.e4","volume":"31","author":"E Drakos","year":"2007","unstructured":"Drakos E, Leventaki V, Schlette EJ, Jones D, Lin P, Medeiros LJ, et al. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. Am J Surg Pathol. 2007;31:447\u201353.","journal-title":"Am J Surg Pathol"},{"key":"1173_CR27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1365-2133.2007.08150.x","volume":"157","author":"X Mao","year":"2007","unstructured":"Mao X, Orchard G, Russell-Jones R, Whittaker S. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas. Br J Dermatol. 2007;157:914\u201321.","journal-title":"Br J Dermatol"},{"key":"1173_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-13-18","volume":"13","author":"I Hammami","year":"2012","unstructured":"Hammami I, Chen J, Murschel F, Bronte V, De Crescenzo G, Jolicoeur M. Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models. BMC Cell Biol. 2012;13:18.","journal-title":"BMC Cell Biol"},{"key":"1173_CR29","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1016\/j.celrep.2017.08.098","volume":"20","author":"J Newson","year":"2017","unstructured":"Newson J, Motwani MP, Kendall AC, Nicolaou A, Muccioli GG, Alhouayek M, et al. Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1\/mPGES-1-derived prostaglandin E(2). Cell Rep. 2017;20:3162\u201375.","journal-title":"Cell Rep"},{"key":"1173_CR30","doi-asserted-by":"publisher","first-page":"5812","DOI":"10.1158\/0008-5472.CAN-12-1098","volume":"72","author":"ML McCleland","year":"2012","unstructured":"McCleland ML, Adler AS, Shang Y, Hunsaker T, Truong T, Peterson D, et al. An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer. Cancer Res. 2012;72:5812\u201323.","journal-title":"Cancer Res"},{"key":"1173_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/1078-0432.CCR-12-2638","volume":"19","author":"ML McCleland","year":"2013","unstructured":"McCleland ML, Adler AS, Deming L, Cosino E, Lee L, Blackwood EM, et al. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas. Clin Cancer Res. 2013;19:773\u201384.","journal-title":"Clin Cancer Res"},{"key":"1173_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0714-9","volume":"19","author":"Y Jia","year":"2019","unstructured":"Jia Y, Qi Y, Wang Y, Ma X, Xu Y, Wang J, et al. Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT\/Notch1 signaling pathway. Cancer Cell Int. 2019;19:9.","journal-title":"Cancer Cell Int"},{"key":"1173_CR33","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1182\/blood-2011-04-351742","volume":"118","author":"SF Elsawa","year":"2011","unstructured":"Elsawa SF, Novak AJ, Ziesmer SC, Almada LL, Hodge LS, Grote DM, et al. Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity. Blood. 2011;118:5540\u20139.","journal-title":"Blood"},{"key":"1173_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/bjh.13198","volume":"168","author":"A Romano","year":"2015","unstructured":"Romano A, Parrinello NL, Vetro C, Forte S, Chiarenza A, Figuera A, et al. Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy. Br J Haematol. 2015;168:689\u2013700.","journal-title":"Br J Haematol"},{"key":"1173_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001223","volume":"8","author":"L Cassetta","year":"2020","unstructured":"Cassetta L, Bruderek K, Skrzeczynska-Moncznik J, Osiecka O, Hu X, Rundgren IM, et al. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation. J Immunother Cancer. 2020;8:e001223.","journal-title":"J Immunother Cancer"},{"key":"1173_CR36","doi-asserted-by":"publisher","first-page":"27676","DOI":"10.18632\/oncotarget.8507","volume":"7","author":"O Marini","year":"2016","unstructured":"Marini O, Spina C, Mimiola E, Cassaro A, Malerba G, Todeschini G, et al. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. Oncotarget. 2016;7:27676\u201388.","journal-title":"Oncotarget"},{"key":"1173_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-3083.2010.02463.x","volume":"72","author":"MK Brimnes","year":"2010","unstructured":"Brimnes MK, Vangsted AJ, Knudsen LM, Gimsing P, Gang AO, Johnsen HE, et al. Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR\u2013\/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma. Scand J Immunol. 2010;72:540\u20137.","journal-title":"Scand J Immunol"},{"key":"1173_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7363084","volume":"2020","author":"H Wang","year":"2020","unstructured":"Wang H, Tao Q, Wang Z, Zhang Q, Xiao H, Zhou M, et al. Circulating monocytic myeloid-derived suppressor cells are elevated and associated with poor prognosis in acute myeloid leukemia. J Immunol Res. 2020;2020:7363084.","journal-title":"J Immunol Res"},{"key":"1173_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104346","volume":"364","author":"YS Lee","year":"2021","unstructured":"Lee YS, Saxena V, Bromberg JS, Scalea JR. G-CSF promotes alloregulatory function of MDSCs through a c-Kit dependent mechanism. Cell Immunol. 2021;364:104346.","journal-title":"Cell Immunol"},{"key":"1173_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep18217","volume":"5","author":"M Kawano","year":"2015","unstructured":"Kawano M, Mabuchi S, Matsumoto Y, Sasano T, Takahashi R, Kuroda H, et al. The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer. Sci Rep. 2015;5:18217.","journal-title":"Sci Rep"},{"key":"1173_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2019.05.019","volume":"25","author":"M Yamashita","year":"2019","unstructured":"Yamashita M, Passegu\u00e9 E. TNF-\u03b1 coordinates hematopoietic stem cell survival and myeloid regeneration. Cell Stem Cell. 2019;25:357\u201372.e7.","journal-title":"Cell Stem Cell"},{"key":"1173_CR42","doi-asserted-by":"publisher","first-page":"557586","DOI":"10.3389\/fimmu.2020.557586","volume":"11","author":"N Karin","year":"2020","unstructured":"Karin N. The development and homing of myeloid-derived suppressor cells: from a two-stage model to a multistep narrative. Front Immunol. 2020;11:557586.","journal-title":"Front Immunol"},{"key":"1173_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ccell.2015.07.006","volume":"28","author":"L Strauss","year":"2015","unstructured":"Strauss L, Sangaletti S, Consonni FM, Szebeni G, Morlacchi S, Totaro MG, et al. RORC1 regulates tumor-promoting \u201cemergency\u201d granulo-monocytopoiesis. Cancer Cell. 2015;28:253\u201369.","journal-title":"Cancer Cell"},{"key":"1173_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molimm.2019.11.014","volume":"117","author":"B-H Li","year":"2020","unstructured":"Li B-H, Garstka MA, Li Z-F. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor. Mol Immunol. 2020;117:201\u201315.","journal-title":"Mol Immunol"},{"key":"1173_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li X, Yao W, Yuan Y, Chen P, Li B, Li J, et al. Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. 2017;66:157\u201367.","journal-title":"Gut"},{"key":"1173_CR46","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.4049\/jimmunol.166.9.5398","volume":"166","author":"DI Gabrilovich","year":"2001","unstructured":"Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol. 2001;166:5398\u2013406.","journal-title":"J Immunol"},{"key":"1173_CR47","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.4049\/jimmunol.167.10.5583","volume":"167","author":"M Saio","year":"2001","unstructured":"Saio M, Radoja S, Marino M, Frey AB. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J Immunol. 2001;167:5583\u201393.","journal-title":"J Immunol"},{"key":"1173_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell. 2020;78:1019\u201333.","journal-title":"Mol Cell"},{"key":"1173_CR49","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41590-018-0229-5","volume":"19","author":"S Patel","year":"2018","unstructured":"Patel S, Fu S, Mastio J, Dominguez GA, Purohit A, Kossenkov A, et al. Unique pattern of neutrophil migration and function during tumor progression. Nat Immunol. 2018;19:1236\u201347.","journal-title":"Nat Immunol"},{"key":"1173_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.","journal-title":"Nat Commun"},{"key":"1173_CR51","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 2016;37:208\u201320.","journal-title":"Trends Immunol"},{"key":"1173_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00475-8","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang S, Zhao X, Wu S, Cui D, Xu Z. Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies. Biomark Res. 2023;11:34.","journal-title":"Biomark Res"},{"key":"1173_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/cc14003","volume":"18","author":"CJ Darcy","year":"2014","unstructured":"Darcy CJ, Minigo G, Piera KA, Davis JS, McNeil YR, Chen Y, et al. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care. 2014;18:R163.","journal-title":"Crit Care"},{"key":"1173_CR54","doi-asserted-by":"publisher","first-page":"e107816","DOI":"10.1371\/journal.pone.0107816","volume":"9","author":"A Gervassi","year":"2014","unstructured":"Gervassi A, Lejarcegui N, Dross S, Jacobson A, Itaya G, Kidzeru E, et al. Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses. PLoS ONE. 2014;9:e107816.","journal-title":"PLoS ONE"},{"key":"1173_CR55","doi-asserted-by":"publisher","first-page":"e20201803","DOI":"10.1084\/jem.20201803","volume":"218","author":"F Veglia","year":"2021","unstructured":"Veglia F, Hashimoto A, Dweep H, Sanseviero E, De Leo A, Tcyganov E, et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. J Exp Med. 2021;218:e20201803.","journal-title":"J Exp Med"},{"key":"1173_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/10428199909167386","volume":"32","author":"T Tsuruta","year":"1999","unstructured":"Tsuruta T, Tani K, Hoshika A, Asano S. Myeloperoxidase gene expression and regulation by myeloid cell growth factors in normal and leukemic cells. Leuk Lymphoma. 1999;32:257\u201367.","journal-title":"Leuk Lymphoma"},{"key":"1173_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/cancers10110443","volume":"10","author":"S Kumar","year":"2018","unstructured":"Kumar S, Xie H, Scicluna P, Lee L, Bj\u00f6rnhagen V, H\u00f6\u00f6g A, et al. MiR-375 regulation of LDHB plays distinct roles in polyomavirus-positive and -negative Merkel cell carcinoma. Cancers. 2018;10:443.","journal-title":"Cancers"},{"key":"1173_CR58","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3389\/fonc.2020.01530","volume":"10","author":"V Sasidharan Nair","year":"2020","unstructured":"Sasidharan Nair V, Saleh R, Toor SM, Alajez NM, Elkord E. Transcriptomic analyses of myeloid-derived suppressor cell subsets in the circulation of colorectal cancer patients. Front Oncol. 2020;10:1530.","journal-title":"Front Oncol"},{"key":"1173_CR59","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/2211-5463.13445","volume":"12","author":"K He","year":"2022","unstructured":"He K, Liu X, Hoffman RD, Shi R-Z, Lv G-Y, Gao J-L. G-CSF\/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors. FEBS Open Bio. 2022;12:1268\u201385.","journal-title":"FEBS Open Bio"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01173-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:02:22Z","timestamp":1734505342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01173-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1038\/s41408-024-01173-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4144316\/v1","asserted-by":"object"}]},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in strict accordance with relevant guidelines and regulations. Written informed consent was obtained from all participants in compliance with the Mayo Clinic Institutional Review Board (IRB) requirements (IRB-118-01). The study adhered to the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"217"}}